Name: Latest research reports of Ajanta Pharma Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Turnaround Potential

2852.7000 35.40 (1.26%)

NSE Feb 06, 2026 15:31 PM

Volume: 107.6K

Ajanta Pharma Ltd.

28 Jul 2023

2852.70

1.26%

Ajanta Pharma (BUY): Q1 beat sparked by sharp margin recovery

Buy: Ajanta Pharma Ltd.

Target

BOB Capital Markets Ltd.

Strong Q1 beat with EBITDA/PAT of Rs 2.7bn/Rs 2.1bn coming in 17%/ 39% ahead of consensus due to margin recovery

Ajanta Pharma Ltd. is trading above all available SMAs